{"id":193479,"date":"2026-08-10T12:47:24","date_gmt":"2026-08-10T07:17:24","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=193479"},"modified":"2026-08-10T12:47:25","modified_gmt":"2026-08-10T07:17:25","slug":"advanced-enzyme-q1-results-fy27-pat-38-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/","title":{"rendered":"Advanced Enzyme Q1 FY27 Results: Revenue Rs 189 Cr, PAT Rs 38 Cr and Key Highlights"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Advanced Enzyme Q1 FY27 results declared August 8, 2026. Revenue Rs 189 Cr (+2.08% YoY). PAT Rs 38 Cr (-4.58% YoY). CMP Rs 324.35 (-1.65%).<\/em><\/p>\n<p>Advanced Enzyme Q1 FY27 results were announced on August 8, 2026, consolidated. Revenue grew +2.08% YoY to Rs 189 Cr from Rs 185 Cr in Q1 FY26.<\/p>\n<p>Operating profit stood at Rs 41 Cr (-12.24% YoY). PAT came in at Rs 38 Cr (-4.58% YoY), offering a comprehensive view of how Advanced Enzyme is navigating the current chemicals\/biotech environment.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=advanced-enzyme-q1-fy27\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#Advanced_Enzyme_Q1_FY27_Financial_Highlights\" title=\"Advanced Enzyme Q1 FY27 Financial Highlights\">Advanced Enzyme Q1 FY27 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#Advanced_Enzyme_Q1_FY27_Performance_Analysis\" title=\"Advanced Enzyme Q1 FY27 Performance Analysis\">Advanced Enzyme Q1 FY27 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#Key_Business_Factors_in_Advanced_Enzyme_Q1_FY27_Results\" title=\"Key Business Factors in Advanced Enzyme Q1 FY27 Results\">Key Business Factors in Advanced Enzyme Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#Revenue_Expansion_Driving_Top-Line_Growth\" title=\"Revenue Expansion Driving Top-Line Growth\">Revenue Expansion Driving Top-Line Growth<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#Margin_Pressure_from_Cost_Headwinds\" title=\"Margin Pressure from Cost Headwinds\">Margin Pressure from Cost Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#PAT_Performance_and_Profitability_Trend\" title=\"PAT Performance and Profitability Trend\">PAT Performance and Profitability Trend<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#Dividend_Details\" title=\"Dividend Details\">Dividend Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#FY27_Outlook_for_Advanced_Enzyme\" title=\"FY27 Outlook for Advanced Enzyme\">FY27 Outlook for Advanced Enzyme<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#Advanced_Enzyme_Stock_Performance_After_Q1_FY27_Results\" title=\"Advanced Enzyme Stock Performance After Q1 FY27 Results\">Advanced Enzyme Stock Performance After Q1 FY27 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#Key_Risks_for_Advanced_Enzyme\" title=\"Key Risks for Advanced Enzyme\">Key Risks for Advanced Enzyme<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#Sector-Specific_Risks\" title=\"Sector-Specific Risks\">Sector-Specific Risks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#Valuation_and_Earnings_Risk\" title=\"Valuation and Earnings Risk\">Valuation and Earnings Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#Operational_and_Financial_Risk\" title=\"Operational and Financial Risk\">Operational and Financial Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#Frequently_Asked_Questions_on_Advanced_Enzyme_Q1_FY27_Results\" title=\"Frequently Asked Questions on Advanced Enzyme Q1 FY27 Results\">Frequently Asked Questions on Advanced Enzyme Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#When_were_Advanced_Enzyme_Q1_FY27_results_declared\" title=\"When were Advanced Enzyme Q1 FY27 results declared?\">When were Advanced Enzyme Q1 FY27 results declared?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#What_was_Advanced_Enzyme_revenue_in_Q1_FY27\" title=\"What was Advanced Enzyme revenue in Q1 FY27?\">What was Advanced Enzyme revenue in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#What_was_Advanced_Enzyme_PAT_in_Q1_FY27\" title=\"What was Advanced Enzyme PAT in Q1 FY27?\">What was Advanced Enzyme PAT in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#Did_Advanced_Enzyme_declare_a_dividend_in_Q1_FY27\" title=\"Did Advanced Enzyme declare a dividend in Q1 FY27?\">Did Advanced Enzyme declare a dividend in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#What_is_the_FY27_outlook_for_Advanced_Enzyme\" title=\"What is the FY27 outlook for Advanced Enzyme?\">What is the FY27 outlook for Advanced Enzyme?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/advanced-enzyme-q1-results-fy27-pat-38-crore\/#How_did_Advanced_Enzyme_stock_react_to_Q1_FY27_results\" title=\"How did Advanced Enzyme stock react to Q1 FY27 results?\">How did Advanced Enzyme stock react to Q1 FY27 results?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Advanced_Enzyme_Q1_FY27_Financial_Highlights\"><\/span><strong>Advanced Enzyme Q1 FY27 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse; font-size: 14px;\">\n<thead>\n<tr style=\"background: #0A0E1A; color: #ffffff;\">\n<th style=\"padding: 10px; text-align: left; border: 1px solid #DDD;\">Metric<\/th>\n<th style=\"padding: 10px; text-align: center; border: 1px solid #DDD;\">Q1 FY27 (Rs Cr)<\/th>\n<th style=\"padding: 10px; text-align: center; border: 1px solid #DDD;\">Q1 FY26 (Rs Cr)<\/th>\n<th style=\"padding: 10px; text-align: center; border: 1px solid #DDD;\">YoY Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDD;\">Advanced Enzyme Revenue<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">189<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">185<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD; color: green;\">+2.08%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDD;\">Operating Profit<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">41<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">46<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD; color: red;\">-12.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDD;\">Net Profit (PAT)<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">38<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">40<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD; color: red;\">-4.58%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDD;\">Reporting Basis<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\" colspan=\"3\">Consolidated<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Advanced_Enzyme_Q1_FY27_Performance_Analysis\"><\/span><strong>Advanced Enzyme Q1 FY27 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for Live Data on This Stock<\/strong><\/a><\/p>\n<p>Advanced Enzyme Q1 FY27 results reflect modest fundamentals across key financial metrics. Revenue moderated slightly with the top line reaching Rs 189 Cr for the April to June 2026 quarter.<\/p>\n<p>Operating profit contracted -12.24% YoY to Rs 41 Cr. Management is focused on cost rationalisation to restore operating leverage.<\/p>\n<p>PAT of Rs 38 Cr marks a -4.58% YoY movement in Advanced Enzyme Q1 FY27 results. Investors monitoring Advanced Enzyme Q1 FY27 results will note this as a key FY27 performance milestone.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_in_Advanced_Enzyme_Q1_FY27_Results\"><\/span><strong>Key Business Factors in Advanced Enzyme Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_Expansion_Driving_Top-Line_Growth\"><\/span><strong>Revenue Expansion Driving Top-Line Growth<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Advanced Enzyme Q1 FY27 results show top-line strength with revenue growing +2.08% YoY to Rs 189 Cr from Rs 185 Cr in Q1 FY26. Steady volume-led growth and disciplined pricing supported the revenue uptick.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Margin_Pressure_from_Cost_Headwinds\"><\/span><strong>Margin Pressure from Cost Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Operating profit in Advanced Enzyme Q1 FY27 results stood at Rs 41 Cr ((-12.24% YoY)), reflecting input cost inflation, wage pressures, and competitive pricing dynamics in the chemicals\/biotech business.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"PAT_Performance_and_Profitability_Trend\"><\/span><strong>PAT Performance and Profitability Trend<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Net profit (PAT) in Advanced Enzyme Q1 FY27 results stood at Rs 38 Cr ((-4.58% YoY)). Near-term PAT moderation is being managed through cost optimisation and revenue diversification.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dividend_Details\"><\/span><strong>Dividend Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No dividend was announced alongside Advanced Enzyme Q1 FY27 results. The company is likely channelling earnings toward business reinvestment and working capital needs.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_for_Advanced_Enzyme\"><\/span><strong>FY27 Outlook for Advanced Enzyme<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Following Advanced Enzyme Q1 FY27 results, management has reiterated a recovery-focused strategy targeting operational efficiencies, cost rationalisation, and revenue diversification. The pace of recovery in the chemicals\/biotech segment will be a key monitorable for investors tracking Advanced Enzyme Q1 FY27 results. Consult a SEBI-registered financial advisor before making decisions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Advanced_Enzyme_Stock_Performance_After_Q1_FY27_Results\"><\/span><strong>Advanced Enzyme Stock Performance After Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Advanced Enzyme live price and get daily stock recommendations.<\/em><\/p>\n<p>Advanced Enzyme shares were trading lower at Rs 324.35 (-1.65%) on August 8, 2026, reflecting investor sentiment on the Advanced Enzyme Q1 FY27 results and near-term sector outlook. The CMP of Rs 324.35 on the results date reflects broader market and sector sentiment in the chemicals\/biotech space.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_for_Advanced_Enzyme\"><\/span><strong>Key Risks for Advanced Enzyme<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Sector-Specific_Risks\"><\/span><strong>Sector-Specific Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Regulatory approvals and feedstock cost volatility are near-term concerns.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_and_Earnings_Risk\"><\/span><strong>Valuation and Earnings Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sustained earnings pressure may delay re-rating; near-term earnings visibility remains limited.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Operational_and_Financial_Risk\"><\/span><strong>Operational and Financial Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Subsidiary-level losses or underperforming overseas operations could drag consolidated PAT lower.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Advanced Enzyme Q1 FY27 results reflect modest performance with revenue at Rs 189 Cr and PAT at Rs 38 Cr on a Consolidated basis. Operating leverage and sector tailwinds will determine the FY27 growth trajectory. Investors should review management commentary and sector developments before taking positions.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Advanced_Enzyme_Q1_FY27_Results\"><\/span><strong>Frequently Asked Questions on Advanced Enzyme Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"When_were_Advanced_Enzyme_Q1_FY27_results_declared\"><\/span><strong>When were Advanced Enzyme Q1 FY27 results declared?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Advanced Enzyme Q1 FY27 results were declared on August 8, 2026, covering the April to June 2026 quarter on a Consolidated basis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Advanced_Enzyme_revenue_in_Q1_FY27\"><\/span><strong>What was Advanced Enzyme revenue in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Advanced Enzyme Q1 FY27 results show revenue of Rs 189 Cr, +2.08% compared to Rs 185 Cr in Q1 FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Advanced_Enzyme_PAT_in_Q1_FY27\"><\/span><strong>What was Advanced Enzyme PAT in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net profit in Advanced Enzyme Q1 FY27 results was Rs 38 Cr, -4.58% year-on-year.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Advanced_Enzyme_declare_a_dividend_in_Q1_FY27\"><\/span><strong>Did Advanced Enzyme declare a dividend in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No dividend was announced alongside Advanced Enzyme Q1 FY27 results. Check the official NSE and BSE announcements for future dividend declarations.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_FY27_outlook_for_Advanced_Enzyme\"><\/span><strong>What is the FY27 outlook for Advanced Enzyme?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Management has guided operational restructuring and return to profitability for FY27. Sector trends and order visibility will be key monitorables for investors.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Advanced_Enzyme_stock_react_to_Q1_FY27_results\"><\/span><strong>How did Advanced Enzyme stock react to Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Advanced Enzyme shares were trading lower at Rs 324.35 (-1.65%) on August 8, 2026 following the Advanced Enzyme Q1 FY27 results. Always consult a SEBI-registered financial advisor before acting on stock price movements.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Advanced Enzyme Q1 FY27 results: Revenue Rs 189 Cr (+2.08% YoY), PAT Rs 38 Cr (-4.58% YoY). Key highlights, financial analysis and FY27 outlook.<\/p>\n","protected":false},"author":28,"featured_media":193477,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-193479","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["193477"],"_edit_lock":["1786346249:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["77"],"rank_math_title":["Advanced Enzyme Q1 FY27 Results: Revenue, PAT &amp; Key Highlights"],"rank_math_description":["Advanced Enzyme Q1 FY27 results: Revenue Rs 189 Cr (+2.08% YoY), PAT Rs 38 Cr (-4.58% YoY). Key highlights, financial analysis and FY27 outlook."],"rank_math_focus_keyword":["Advanced Enzyme Q1 FY27 results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["35370"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/advanced-enzyme-q1-results-fy27-pat-38-crore.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/193479","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=193479"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/193479\/revisions"}],"predecessor-version":[{"id":193528,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/193479\/revisions\/193528"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/193477"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=193479"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=193479"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=193479"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}